Investigating Muscle Training's Respiratory Outcomes and Voice Enhancement in Parkinson's Disease

N/ANot Yet RecruitingNCT06473428

National Taiwan University Hospital45 enrolled

Overview

This study aims to investigate the effects of different types of respiratory muscle training on lung function, diaphragm movement, and voice quality in patients with Parkinson's disease (PD). PD often leads to breathing difficulties and voice abnormalities due to weakened respiratory muscles and reduced diaphragm mobility. The study will involve 45 participants with PD, randomly assigned to three groups: one group will perform inspiratory muscle training, the second group will perform both inspiratory and expiratory muscle training, and the third group will receive placebo-controlled expiratory muscle training. The hypothesis is that targeted respiratory muscle training will significantly improve pulmonary function, diaphragm excursion, and phonatory measures compared to the placebo group. The findings aim to develop effective rehabilitation strategies to enhance the quality of life and communication abilities in individuals with PD.

This study aims to investigate the effects of respiratory muscle training on pulmonary function, diaphragm excursion, and phonatory measures in patients with Parkinson's disease (PD). PD often leads to weakened respiratory muscles, reduced diaphragm movement, and voice abnormalities, impacting breathing and communication. The study will recruit 45 patients with PD, who will be randomly assigned to three groups: an inspiratory muscle training group, a combined inspiratory and expiratory muscle training group, and a placebo-controlled expiratory muscle training group. Over eight weeks, participants will perform daily training sessions, with the intensity of the exercises adjusted periodically. Assessments will include pulmonary function tests, ultrasound measurements of diaphragm thickness and movement, and various phonatory evaluations. The hypothesis is that respiratory muscle training will significantly improve respiratory and phonatory functions in PD patients compared to placebo, providing insights into effective rehabilitation strategies for enhancing their quality of life and communication abilities.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

Interventions

respiratory muscle trainingBEHAVIORAL

Inspiratory muscle training with two sessions per day, five repetitions per session, six days a week for eight weeks.

Expiratory Muscle TrainingBEHAVIORAL

Expiratory muscle training with two sessions per day, five repetitions per session, six days a week for eight weeks.

Placebo-Controlled Expiratory Muscle TrainingBEHAVIORAL

Placebo-controlled expiratory muscle training with two sessions per day, five repetitions per session, six days a week for eight weeks.

Eligibility

Sex: ALLMin age: 30 YearsMax age: 85 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with Parkinson's disease (Hoehn \& Yahr stage I-III), * Patients aged 30-85 * Patients with stable medical condition, regular medication adherence, and ability to follow instructions. Exclusion Criteria: * Patients with cognitive impairment * Patients with respiratory or other neurological diseases * Patients with smoking history * Patients with respiratory complications * Patients with recent chest/abdominal surgery * Patients with clinical instability * Patients who are unable to perform pulmonary function tests correctly

Outcomes

Primary Outcomes

Forced Vital Capacity (FVC)

This measure will assess the forced vital capacity (FVC) to evaluate the maximum amount of air a person can forcibly exhale from the lungs after taking the deepest breath possible.